[ORGANIZATION]
Trodelvy
Featured in 2 tracked stories · first seen
Situations
Oncology drug withdrawals in Greece
4 clusters · 14 sources · last updated
Latest: Greece healthcare faces drug shortages and hospital delays
Pharmaceutical company Gilead has announced plans to withdraw its innovative breast cancer drug, Trodelvy (sacituzumab govitecan), from the Greek market by the end of the year. The medication is used to treat metastatic,
Also covered in
-
Anvisa approves new uses for triple-negative breast cancer drug
[HEALTH] · 11 sources ·